Floatz logo

Isavuconazole

Invasive Fungal Infections

Astellas Pharma IncSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Invasive Fungal Infections cohort.

Asset / SponsorPhaseRating
Fluconazole
Radboud University Medical Center
Phase 4BB
Oxygen
Jay C. Buckey Jr.
Phase 4BB
Fosmanogepix
Basilea Pharmaceutica
Phase 2CCC
MICAFUNGIN
Astellas Pharma Europe B.V.
D

Same molecule, other indications

Isavuconazole is also rated in:

aspergillosisDormant
BB
Indicative ·
64 / 100
View asset →
acute myeloid leukemiaDormant
B
Indicative ·
62 / 100
View asset →
primary central nervous system lymphomaDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →